All data are based on the daily closing price as of July 17, 2024
k

Komipharm International

041960.KQ
3.04 USD
-0.01
-0.33%

Overview

Last close
3.04 usd
Market cap
176.01M usd
52 week high
5.58 usd
52 week low
2.93 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
6.8095
Price/Book Value
5.1801
Enterprise Value
233.78M usd
EV/Revenue
7.5532
EV/EBITDA
942.5668

Key financials

Revenue TTM
28.89M usd
Gross Profit TTM
8.06M usd
EBITDA TTM
216633.86 usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
85.89M usd
Net debt
22.16M usd

About

Komipharm International Co., Ltd. manufactures and sells veterinary vaccines, veterinary pharmaceuticals and disinfectants, and bio-fertilizers internationally. It also develops anticancer drugs and pain-relieving agents, which include Kominox, an arsenic-based oral drug; and Panaphix, a non-narcotic cancer pain reliever, as well as provides clinical pathological experiment, test, and analysis services. The company was formerly known as Korea Microbiological Laboratories Co., Ltd. and changed its name to Komipharm International Co., Ltd. in September 2004. The company was founded in 1972 and is headquartered in Siheung, South Korea.
  • Symbol
    041960.KQ
  • Exchange
    KQ
  • Isin
    KR7041960006
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Pharmaceuticals
  • CEO
  • Headquarter
    Siheung-Si
  • Web site
    https://www.komipharm.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top